Report Overview

Global 3D Printed Drugs Market, 2028 - Industry Trends & Forecast Report 2028

Global 3D Printed Drugs Market - Overview

Technology advancements in 3D printing processes, the drug's immediate solubility in the mouth, and an increase in the number of epilepsy sufferers are major growth factors for Global 3D Printer Drugs Market. The market for 3D printed medicines is also driven by the rising interest in the technology, technology advancements, and R&D investments made by top global pharmaceutical firms, such as GlaxoSmithKline. However, the absence of government regulations and the unfavorable side effects of 3D printed drugs could limit the market growth. To provide people with safe and effective customized pharmaceuticals, 3D printed drugs are prescriptions that are made utilizing the 3D printing technique. These drugs need not to be swallowed whole, because of their unitary porous construction, which disperses readily in the mouth. It makes it simple for producers to change the size, appearance, form, and rate of distribution of a variety of medications.

Global 3D Printed Drugs Market Industry Trends and Market Forecast

BlueWeave Consulting, a leading strategic consulting and market research firm, estimated Global 3D Printed Drugs Market size at USD 347.2 million in 2021. From 2022 to 2028, the market is forecast to grow at a compound annual growth rate (CAGR) of 16.4% to reach a size of USD 965.7 million by 2028. Global market for 3D\ printed medicines is rapidly growing as a result of the lowering 3D printer costs. In the coming years, the market growth is expected to be boosted by the growing use of 3D printing as an additive in the medical and healthcare sectors. In addition, it is predicted that the growing trend of creating prosthetic bones utilizing 3D printing technology will further enhance the market growth.

Growth Drivers

Spurring Demand for Customized and Combination Drugs

An increasing demand for personalized medications and the rapidly expanding R&D activities that support 3D printing are driving Global 3D Printed Drugs Market. The 3D technology is enabling the development of personalized medical treatments, which opens up a slew of new possibilities for improving patient care. The rising prevalence of chronic diseases, the growing demand for less expensive medications or tablets, and the expanding use of 3D printing in the healthcare industry are all growth factors for the market. Pharmaceuticals created through 3D printing are gaining popularity, as they are simple to consume and practically instantly dissolve. Additionally, they are more able to help patients than batch-produced medications as they may be tailored to each patient’s unique needs. Hence, the market for 3D printed medications is expected to expand during the forecast period.

Restraints

Adverse Side Effects and Absence of Regulations

The adverse effects of these drugs, as well as the lack of government regulations for 3D printed products are two main factors that may impede the growth of global market for 3D printed medications.

Segmental Coverage

Global 3D Printed Drugs Market - By Technology

In Global 3D Printed Drugs Market by technology, the zip dose market category had the highest market share in 2021. This medication technology is simple to utilize and helpful for dysphagia patients.  The market is expanding as a result of the rising demand from elderly and young patients for medications that dissolve fast in the mouth. On the other hand, it is anticipated that inkjet printer technology would advance at the highest rate during the projected period. Patients use it frequently because it consistently produces 3D medications and has technological advantages over competing methods. Inkjet printing is a technique for depositing three-dimensional structures in solid dosage forms. Using different combinations of active pharmaceutical ingredients (APIs) and excipients (inks), rising epilepsy rates, ongoing 3D printing technological developments, and growing consumer awareness of this technology in developing countries are the main factors driving the market expansion.

Global 3D Printed Drugs Market - By Application

The neurology application segment leads Global 3D Printed Drugs Market by application. In August 2015, the FDA approved Aprecia Pharmaceuticals SPRITAM (levetiracetam) pills for the management of epilepsy. This is the only drug that has been approved and is available. This authorization has enhanced the pharmaceutical industry's interest in making investments in this field, which is driving market expansion. A growth in the prevalence of different neurological illnesses, such as Parkinson's disease, is another factor driving the category. A group of experts from Germany and the Netherlands used 3D printing technology to create the Mini-Floating-Polypill as a treatment for Parkinson's disease, according to a study that was published in April 2022. For this investigation, fused deposition modeling (FDM) was employed. These research initiatives are expected to support segment growth. On the other hand, orthopedic treatments are difficult and complex, and novel strategies are required to get around a number of well-known problems and improve patient outcomes. Complications, particularly those with a high infection rate, may frequently cause prolonged patient suffering and functional loss. As a result, orthopedic medications can be utilized to treat postoperative infections, fueling market expansion.

Source: BlueWeave Consulting

Global 3D Printed Drugs Market – By End User

In Global 3D Printed Drugs Market by end user, the hospitals and clinics segment held the highest market share in 2021. The widespread use of prescription drugs to treat a variety of chronic diseases is expanding the market for customized pharmaceuticals. The market is also being driven by the increasing demand for pharmaceuticals and the economically advantageous use of bio-drugs that utilize this technology. 3D printers can also be deployed in hospitals and clinics to allow for the on-demand production of drugs, particularly those that have low stability or need to be kept in a cold chain. It can also significantly reduce costs, waste, and environmental stress. These elements are expected to accelerate the use of 3D printed medicines in hospitals and clinics.

Impact of covid-19 on Global 3D Printed Drugs Market

Market expansion is anticipated to benefit from the COVID-19 epidemic. A variety of printers have been launched by operating companies in the advanced manufacturing industry to help increase production of medications and other necessary commodities. Therefore, it is anticipated that use of these technologies will grow during the COVID-19 pandemic.

Global 3D Printed Drugs Market – Regional Coverage

North America dominates Global 3D Printed Drugs Market by regions. It leadership position can be ascribed to the rising prevalence of chronic diseases, the superior domestic healthcare infrastructure, significant R&D spending, and the region's expanding adoption of technology advancements. As a result of major technology advancements in 3D printed medicine techniques made by China and Japan, the Asia-Pacific region is forecast to record its growth at the highest rate. Furthermore, the expansion of clinical development frameworks, R&D, and healthcare infrastructure in developing countries, such as India, has set the Asia-Pacific market up for lucrative growth prospects over the course of the projected period. Due to the rising health consciousness among Europeans, the Europe area is also anticipated to experience reasonable growth during the projection period.

Competitive landscape

Global 3D Printed Drugs Market's prominent players are focusing on providing advanced and innovative solutions to meet the needs of the industries. Aprecia Pharmaceuticals LLC, Bioduro, Affinity, Acrux, AstraZeneca, Biomedical Modeling Inc., BV LLC, GlaxoSmithKline Plc, FabRx Ltd, Hewlett Packard Caribe, Merck KGaA, Cycle Pharmaceuticals, and Tvasta are major players active in the market.

Recent Developments

Natural Machines and CurfiyLabs worked together in March 2022 to manufacture 3D printed medications in accordance with the specific demands of the patients. This should make it possible for pharmaceutical companies and hospitals get their medication more quickly.

Scope of the Report

By Technology

• Direct Write
• Fused Deposition modeling
• Inkjet printing
• Powder bed printing
• zip dose
• Stereolithography

By Application

• Neurology
• Orthopedic
• Dental or medical implants
• Hearing & Audibility Aid

By End User

• Hospital
• Clinics
• Research Laboratories

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Research Methodology
   1. Qualitative Research
      1. Primary & Secondary Research
   2. Quantitative Research
   3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
   4. Breakdown of Primary Research Respondents, By Region
   5. Assumption & Limitation
3. Executive Summary
4. Global 3D Printed Drugs Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   3. Technology Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
5. Global 3D Printed Drugs Market Overview
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Technology
         1. Direct Write
         2. Fused Deposition Modeling
         3. Inkjet Printing
         4. Powder Bed Printing
         5. Stereolithography
         6. Zip Dose
      2. By Application
         1. Neurology
         2. Orthopedic
         3. Hearing & Audibility Aid
         4. Dental or Medical Implants
         5. Others
      3. By End User
         1. Hospital
         2. Clinics
         3. Research Laboratories
         4. Others
      4. By Region
         1. North America
         2. Europe
         3. The Asia Pacific
         4. Latin America
         5. Middle East and Africa
6. North America 3D Printed Drugs Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Country
         1. United States
         2. Canada
7. Europe 3D Printed Drugs Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Country
         1. Germany
         2. United Kingdom
         3. Italy
         4. France
         5. Spain
         6. Rest of Europe
8. Asia Pacific 3D Printed Drugs Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of Asia Pacific
9. Latin America 3D Printed Drugs Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Country
         1. Brazil
         2. Mexico
         3. Rest of Latin America
10. Middle East & Africa 3D Printed Drugs Market
    1. Market Size & Forecast by Value, 2018-2028
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Technology
       2. By Application
       3. By End User
       4. By Country
          1. Saudi Arabia
          2. UAE
          3. South Africa
          4. Rest of Middle East & Africa
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
12. Impact of Covid-19 on Global 3D Printed Drugs Market
13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
    1. Aprecia
    2. Bioduro
    3. Affnity
    4. Acrux
    5. Tvasta
    6. FabRx
    7. AstraZeneca
    8. BV LLC
    9. Biomedical Modeling Inc.
    10. General Electric Company
    11. Other Prominent Players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

Figure 1: Global 3D Printed Drugs Market Segmentation

Figure 2: Global 3D Printed Drugs Industry Value Chain Analysis

Figure 3: Global 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028

Figure 4: Global 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028

Figure 5: Global 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028

Figure 6: Global 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028

Figure 7: Global 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028

Figure 8: North America 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028

Figure 9: North America 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028

Figure 10: North America 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028

Figure 11: North America 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028

Figure 12: North America 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028

Figure 13: Europe 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028

Figure 14: Europe 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028

Figure 15: Europe 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028

Figure 16: Europe 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028

Figure 17: Europe 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028

Figure 18: Asia-Pacific 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028

Figure 19: Asia-Pacific 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028

Figure 20: Asia-Pacific 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028

Figure 21: Asia-Pacific 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028

Figure 22: Asia-Pacific 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028

Figure 23: Latin America 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028

Figure 24: Latin America 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028

Figure 25: Latin America 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028

Figure 26: Latin America 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028

Figure 27: Latin America 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028

Figure 28: Middle East & Africa 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028

Figure 29: Middle East & Africa 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028

Figure 30: Middle East & Africa 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028

Figure 31: Middle East & Africa 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028

Figure 32: Middle East & Africa 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028

Figure 33: Global 3D Printed Drugs Market Share Analysis, 2021

List of Tables

Table 1: Global 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028

Table 2: Global 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028

Table 3: Global 3D Printed Drugs Market Size. By Application, By Value (USD Million), 2018-2028

Table 4: Global 3D Printed Drugs Market Size. By Country, By Value (USD Million), 2018-2028

Table 5: North America 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028

Table 6: North America 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028

Table 7: 28 North America 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028

Table 8: 28 North America 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028

Table 9: Europe 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028

Table 10: Europe 3D Printed Drugs Market Size, By Technology, By Value (USD Million), By Value 2018-2028

Table 11: 40 Europe 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028

Table 12: 40 Europe 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028

Table 13: Asia-Pacific 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028

Table 14: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Technology, By Value 2018-2028

Table 15: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028

Table 16: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028

Table 17: Latin America 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028

Table 18: Latin America 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028

Table 19: Latin America 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028

Table 20: Latin America 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028

Table 21: Middle East & Africa 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028

Table 22: Middle East & Africa 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028

Table 23: Middle East & Africa 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028

Table 24: Middle East & Africa 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028

Table 25: List of Key Players and Their Offerings

Table 26: Competitive Benchmarking, by Operating Parameters

Table 27 Aprecia Company Overview

Table 28 Aprecia Financial Overview

Table 29        Bioduro Company Overview

Table 30        Bioduro Financial Overview

Table 31        Affnity Company Overview

Table 32        Affnity Financial Overview

Table 33        Acrux Company Overview

Table 34        Acrux Financial Overview

Table 35        Tvasta Company Overview

Table 36        Tvasta Financial Overview

Table 37        FabRx Ltd Company Overview

Table 38        FabRx Ltd Financial Overview

Table 39        AstraZeneca Company Overview

Table 40        AstraZeneca Financial Overview

Table 41        BV LLC Company Overview

Table 42        BV LLC Financial Overview

Table 43        Biomedical Modeling Inc. Company Overview

Table 44        Biomedical Modeling Inc. Financial Overview

Table 45        General Electric Company Overview

Table 46        General Electric Company Financial Overview